NZpharma
Board
1 director, since incorporationDirector (not named in the articles)
since 17-11-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 10-09-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 11. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”deed of 21-11-2023
Mandates through the years
1 name, the dashed line is todayNzouakeu Tankoua Stella Morelle
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- Nzouakeu Tankoua Stella Morelle
- Director (not named in the articles), from 17-11-2023 to date
Control
Capital
- Contribution
- €3,000
- Shares
- 1,000
- Contribution per share
- €3
- Equity per share
- €65.00 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 21-11-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Pour moitié à charge du cédant et pour moitié à charge du ou des acquéreurs proportionnellement au nombre d'actions acquises, nullité”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 18:00
Shareholders
At incorporation
deed of 21-11-2023 ↗
- Nzouakeu Tankoua Stella Morelle 1,000 shares (100%)